The 2021 Treatment Guidelines for Rheumatoid Arthritis

The American College of Rheumatology has updated its treatment guidelines for rheumatoid arthritis. The guideline includes 44 treatment recommendations, 7 of which are now strongly recommended. They address administration of methotrexate, treat-to-target for patients naïve to biologic disease modifying anti-rheumatic drugs (bDMARDs) or targeted synthetic DMARDS (tsDMARDs), and prophylactic antiviral therapy for patients initiating rituximab who are hepatitis B core antibody positive.

In this slideshow, we highlight the 7 strongest recommendations.

Be sure to check out Rheumatology Network's Expert Perspective on the Management of Psoriatic Arthritis with Christopher Parker, DO.

Reference:

Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis [published online ahead of print, 2021 Jun 8]. Arthritis Care Res (Hoboken). 2021;10.1002/acr.24596. doi:10.1002/acr.24596